Patents by Inventor Prakash Ambady

Prakash Ambady has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Morpholino oligonucleotides useful in cancer treatment
    Patent number: 11679121
    Abstract: Disclosed are morpholino oligonucleotides that can be used to silence expression of MGMT, pharmaceutical compositions that include said morpholino oligonucleotides, and methods of using said morpholino oligonucleotides in the treatment of cancer, particularly methods that involve the use of radiation to deliver said morpholino oligonucleotides.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: June 20, 2023
    Assignees: United States Government As Represented By The Department of Veterans Affairs, Oregon Health & Science University
    Inventors: Prakash Ambady, Jeffrey Wu, Edward Neuwelt
  • Morpholino Oligonucleotides Useful In Cancer Treatment
    Publication number: 20210106608
    Abstract: Disclosed are morpholino oligonucleotides that can be used to silence expression of MGMT, pharmaceutical compositions that include said morpholino oligonucleotides, and methods of using said morpholino oligonucleotides in the treatment of cancer, particularly methods that involve the use of radiation to deliver said morpholino oligonucleotides.
    Type: Application
    Filed: December 7, 2020
    Publication date: April 15, 2021
    Inventors: Prakash Ambady, Jeffrey Wu, Edward Neuwelt
  • Morpholino oligonucleotides useful in cancer treatment
    Patent number: 10857174
    Abstract: Disclosed are morpholino oligonucleotides that can be used to silence expression of MGMT, pharmaceutical compositions that include said morpholino oligonucleotides, and methods of using said morpholino oligonucleotides in the treatment of cancer, particularly methods that involve the use of radiation to deliver said morpholino oligonucleotides.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: December 8, 2020
    Assignees: UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Prakash Ambady, Jeffrey Wu, Edward Neuwelt
  • Morpholino Oligonucleotides Useful In Cancer Treatment
    Publication number: 20200030357
    Abstract: Disclosed are morpholino oligonucleotides that can be used to silence expression of MGMT, pharmaceutical compositions that include said morpholino oligonucleotides, and methods of using said morpholino oligonucleotides in the treatment of cancer, particularly methods that involve the use of radiation to deliver said morpholino oligonucleotides.
    Type: Application
    Filed: July 25, 2019
    Publication date: January 30, 2020
    Inventors: Prakash Ambady, Jeffrey Wu, Edward Neuwelt